U.S. Markets close in 4 hrs 37 mins

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.61+0.21 (+0.98%)
As of 11:22AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.53
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 338.00
52 Week Low 321.34
50-Day Moving Average 326.15
200-Day Moving Average 328.60

Share Statistics

Avg Vol (3 month) 3233.61k
Avg Vol (10 day) 3147.57k
Shares Outstanding 534.83M
Implied Shares Outstanding 6N/A
Float 17.18M
% Held by Insiders 17.23%
% Held by Institutions 197.89%
Shares Short (May 27, 2021) 43.46M
Short Ratio (May 27, 2021) 415.57
Short % of Float (May 27, 2021) 415.72%
Short % of Shares Outstanding (May 27, 2021) 49.92%
Shares Short (prior month Apr 29, 2021) 43.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.97%
Return on Equity (ttm)-45.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-82.41M
Diluted EPS (ttm)-2.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)249.98M
Total Cash Per Share (mrq)7.18
Total Debt (mrq)1.7M
Total Debt/Equity (mrq)0.69
Current Ratio (mrq)25.23
Book Value Per Share (mrq)7.08

Cash Flow Statement

Operating Cash Flow (ttm)-77.83M
Levered Free Cash Flow (ttm)-47.79M